Provided by Tiger Trade Technology Pte. Ltd.

Genenta Science S.p.A.

1.26
+0.07005.88%
Post-market: 1.24-0.0200-1.59%19:46 EDT
Volume:28.01K
Turnover:35.19K
Market Cap:29.72M
PE:-3.24
High:1.29
Open:1.22
Low:1.22
Close:1.19
52wk High:10.00
52wk Low:0.5500
Shares:23.59M
Float Shares:13.87M
Volume Ratio:0.80
T/O Rate:0.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3890
EPS(LYR):-0.3890
ROE:-38.03%
ROA:-17.67%
PB:1.16
PE(LYR):-3.24

Loading ...

Company Profile

Company Name:
Genenta Science S.p.A.
Exchange:
NASDAQ
Establishment Date:
2014
Employees:
9
Office Location:
Via Olgettina No. 58,Milan,Milan,Italy
Zip Code:
20132
Phone:
- -
Fax:
- -
Introduction:
Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. Its lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. The company is developing Temferon for use in the treatment of other solid tumor indications, locally advanced hepatocellular carcinoma, and intra-hepatic cholangiocarcinoma. In addition, it develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.

Directors

Name
Position
Pierluigi Paracchi
Chairman of the Board and Chief Executive Officer and Director and General Manager
Francesco Galimi
Acting Chief Medical Officer and Director and Head of Development
Armon Reza Sharei
Director
Giacomoantonio Paracchi
Director
Miguel Maria Mutti
Director

Shareholders

Name
Position
Pierluigi Paracchi
Chairman of the Board and Chief Executive Officer and Director and General Manager
Richard B. Slansky
Chief Financial Officer
Francesco Galimi
Acting Chief Medical Officer and Director and Head of Development